Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Clinical Immunology and Research
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Thomas Clayton Coleman Author
Subjects of specialization
Affiliation
Interleukin 25, Systemic lupus erythematous, Lupus nephritis, Systemic lupus erythematous disease activity index
Stem Cells Cure Inc, California, USA
Biography
Working at Stem Cells Cure Inc, California, Place of living is USA. Subjects of Specialization are Interleukin 25; Systemic lupus erythematous; Lupus nephritis; Systemic lupus erythematous disease activity index
Publications
Short Article Open Access
Our Cure for Leukemia and Lymphoma: How Our Diversity Insures Our Survival and Leaves No Patient Behind
Author(s): Thomas Clayton Coleman
This year in hospitals across the nation tens of thousands of our loved ones will be diagnosed with some form of Leukaemia or Lymphoma or any number of blood born life-threatening illnesses and many of them will die hopelessly waiting for a viable matching donor that will never come. But what if I were to tell you that those days of waiting are to be over.
... view more»Social Media
Google Scholars / Researchers Sites
